PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 25, 2024Open Access

Next Generation Sequencing of Amplified DNA of Circulating Tumor Cells in Resectable Non-Small Cell Lung Cancer: A Comparative Analysis with Primary Cancer Tissue and Cell-Free DNA

View Full Paper
Ask AI
Bookmark
Share

Authors

WKWoojung KimSCSukki ChoJLJoonseok Lee

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kim et al. (2024) studied this question.

synapsesocial.com/papers/68e6daa8b6db643587656b33https://doi.org/10.21203/rs.3.rs-4278611/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparative genomic analysis of circulating tumor cells and primary tissues in early-stage lung cancer: Unveiling signatures of metastatic potential.2024
  2. 2Application of ctDNA sequencing in patients with metastasized lung cancer.2024
  3. 3Clinical Utility of Circulating Tumor <scp>DNA</scp> for Detecting Lung Cancer Mutations by Targeted Next‐Generation Sequencing With Insufficient Tumor Samples2024
  4. 4Concurrent genomic assessment of circulating tumour cells and ctDNA to guide therapy in metastatic breast cancer2025
  5. 5B-191 Genomic Profile of Circulating Tumor DNA in Advanced Lung Cancer: Comparison with Tissue DNA2024